Is it necessary to stop taking Alpelisib intermittently after taking it for a period of time?

Alpelisib (Alpelisib) is a PI3Kα selective inhibitor, commonly used to treat PIK3CA mutated advanced breast cancer, and is usually used in combination with fulvestrant (Fulvestrant). During treatment, some patients will be concerned about whether intermittent discontinuation of medication is needed to reduce side effects or enhance efficacy. The following are four instructions on whether intermittent discontinuation of Apelix is required after taking it for a period of time:

From the perspective of clinical guidelines and instructions, Apelvis is a continuous oral targeted drug. The standard usage is once a day. It is not recommended to stop the drug intermittently on your own. Intermittent treatment may cause fluctuations in blood drug concentration, affect efficacy, and even accelerate the occurrence of drug resistance. Therefore, regular medication should be continued unless serious adverse reactions occur or a doctor's assessment deems it necessary to suspend the medication.

Some serious side effects may require short-term discontinuation of treatment. Common side effects of Apelvis include hyperglycemia, rash, diarrhea, etc. If a patient experiences grade 3 or above adverse reactions, such as persistent hyperglycemia, extensive rash, or severe liver function abnormalities, doctors usually recommend temporarily discontinuing the drug and adjusting the dose or resuming treatment after the symptoms are relieved. This is part of clinical management rather than "intermittent therapy" in an active setting.

Intermittent discontinuation may affect efficacy control. Studies have shown that the anti-tumor effect of apelvis relies on the continuous inhibition of the PI3K pathway. Once the drug is discontinued, this signaling pathway may be reactivated, leading to tumor progression or increased drug resistance. Especially in the context of PIK3CA mutation, continuous treatment is particularly critical for disease control, so it is not recommended to "rest" or "stop taking it for a few days before taking it again".

Individualized adjustments must be made under the guidance of a doctor. If the patient feels tired, has a reduced quality of life, or is intolerable to the side effects due to long-term medication, he or she can communicate with the attending physician to evaluate whether the regimen is suitable for phased reduction, suspension, or replacement. Some patients can temporarily discontinue medication under monitoring during the stable stage of the disease, but close follow-up is required to ensure that the efficacy and disease control are not affected. Do not decide on the time and frequency of discontinuation on your own.

Reference materials:https://www.drugs.com/